01.Listed in “2025 China AI+ Application Top 50 Excellent Cases”
Recently, the results of the “2025 China AI+ Application Top 50 Excellent Cases” selection, co-hosted by Cls.cn and China STAR Market, were officially announced. Relying on its core product — the general protein design large model AIACCLBIO®, Shanghai Matwings Technology Co., Ltd. was successfully selected into this authoritative list with its multi-field industrial landing application cases, ranking among the 50 enterprises representing the highest level of artificial intelligence implementation in China.
It is reported that this selection aims to discover and recognize AI application practices that have achieved large-scale implementation and created remarkable value across various industries. This event received applications and recommendations from more than 300 enterprises, scientific research institutions and teams nationwide. A total of 50 cases were ultimately shortlisted, covering leading enterprises in various industries such as ByteDance, Tencent, Huawei, Ant Group, JD, CATL, Baidu and Alibaba Health, which represents the benchmark achievements of the integrated development of “AI + industry” in China at present.
02.AIACCLBIO® Large Model Platform Empowers Industrial Upgrading
With its self-developed AIACCLBIO® large protein model, Matwings has been selected for this list. It deeply applies cutting-edge artificial intelligence technologies to the fields of life sciences and biomanufacturing, achieving a paradigm shift from “data-driven” to “intelligent design”, driving industrial upgrading.
Core Technical Highlights and Application Values:
Powerful Versatility: Instead of targeting a single protein or specific tasks, AIACCLBIO® serves as a general design engine with strong generalization capabilities, widely applicable to innovative pharmaceuticals, general health, circular economy, filler and consumables and many other sectors.
Efficiency Revolution: Traditional protein design relies on extensive trial-and-error experiments, featuring long cycles and high costs. Leveraging deep learning algorithms, AIACCLBIO® can rapidly predict and optimize the functions of target proteins within massive sequence spaces, cutting R&D cycles by months or even years and greatly reducing research and development costs.
Precise Empowerment: This model has successfully helped dozens of partners achieve key progress in areas such as biopharmaceutical R&D and industrial enzyme modification, demonstrating robust commercial transformation potential and industrial driving force.
03. Organizer’s Recognition & Industry Significance
As reported by Sci-Tech Innovation Board Daily, the 50 selected enterprises and their AI innovative applications stood out for their high scenario adaptability and tangible empowering outcomes. As a perfect embodiment of this benchmark, Matwings’s case not only demonstrates the disruptive potential of AI in cutting-edge scientific fields, but also validates its capability to address real industrial pain points and deliver genuine economic value.
As an AI-driven technological innovation enterprise, Matwings ’s selection alongside industry leaders including ByteDance and Tencent marks its leading position in the AI for Science track gaining mainstream recognition. This accolade not only affirms the company’s strength in technological R&D, but also acknowledges its contributions to advancing the in-depth integration of AI and life sciences and accelerating the upgrading of the biomedical industry.
Going forward, Matwings will take this honor as a new starting point. It will continue to ramp up R&D investment, advance technological iteration and expand application scenarios of its AIACCLBIO® platform. By partnering with more industrial chain collaborators, the company will jointly explore the boundless potential of artificial intelligence in the life and health sector, and contribute intelligent capabilities to the development of biotechnology and the cause of human health in China and across the globe.
About Matwings
Matwings, founded in 2021 by an elite team from Shanghai Jiao Tong University, is an AI-driven full-stack protein R&D platform company. By building an unparalleled ultra-large-scale protein sequence dataset/label library, Matwings has developed a general large model for protein design on this foundation, enabling precise design of functional proteins directly tailored to industrial demands.
Centered on its self-developed large protein model as the core engine, Matwings has developed a full-stack AI protein R&D platform by integrating scientific research intelligent agents and automated laboratory equipment. The platform covers the entire workflow: market/literature/patent research, molecular design, small-scale validation, pilot-scale process optimization, and ultimately production scale-up. By fully integrating AI into industrial application scenarios, Matwings breaks through the cognitive boundaries of existing human experts, enabling faster and superior development of diverse biological products with proteins as the underlying “chips”, such as innovative drugs, healthcare products, agricultural products, functional foods, and bio-based materials.
